Two studies show that the risk of drug-induced liver injury (DILI) is increased when the daily dose of a drug given by oral route is higher than 10mg per day and/or when the drug undergoes a significant hepatic metabolism. If confirmed, these data suggest that developing drugs with high potency and low hepatic metabolism will reduce the risk of idiosyncratic DILI in man.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gcb.2010.04.015 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!